Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Net Margin Growth (3y) (2012 - 2026)

Analysis

Resmed (RMD) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn -641.00
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 420.00
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 484.00
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 459.00
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 941.00
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn -1,024.00
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 574.00
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 573.00
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 300.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 573.00
Mar 31, 2026 704.00
Dec 31, 2025 584.00
Sep 30, 2025 395.00
Jun 30, 2025 684.00
Mar 31, 2025 755.00
Dec 31, 2024 433.00
Sep 30, 2024 290.00
Jun 30, 2024 162.00
Mar 31, 2024 3,531.00
Dec 31, 2023 -448.00
Sep 30, 2023 -382.00
Jun 30, 2023 -262.00
Mar 31, 2023 -39.00
Dec 31, 2022 -5.00
Sep 30, 2022 451.00
Jun 30, 2022 1,370.00
Mar 31, 2022 479.00
Dec 31, 2021 340.00
Sep 30, 2021 455.00